Epitranscriptomic Modification of MicroRNA Increases Atherosclerosis Susceptibility.
作者信息
He Ming, Dong Jianjie, Wen Junmao, Zhang Yuqing, Han So Yun, Wang Chen, Gongol Brendan, Wei Tong-You Wade, Kang Jian, Huang Hsi-Yuan, Cheng Susan, Shyy John Y-J
机构信息
Division of Cardiology, Department of Medicine, University of California, San Diego, La Jolla (M.H., J.D., J.W., Y.Z., S.Y.H., B.G., T.-Y.W.W., J.K., J.Y-J.S.).
Department of Cardiology, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China (C.W.).
出版信息
Circulation. 2023 Nov 28;148(22):1819-1822. doi: 10.1161/CIRCULATIONAHA.123.065455. Epub 2023 Nov 27.
Abstract
摘要
相似文献
1
Epitranscriptomic Modification of MicroRNA Increases Atherosclerosis Susceptibility.
Circulation. 2023 Nov 28;148(22):1819-1822. doi: 10.1161/CIRCULATIONAHA.123.065455. Epub 2023 Nov 27.
2
Vascular microRNA-204 is remotely governed by the microbiome and impairs endothelium-dependent vasorelaxation by downregulating Sirtuin1.
Nat Commun. 2016 Sep 2;7:12565. doi: 10.1038/ncomms12565.
3
Role of Non-Coding RNAs in Stroke.
Stroke. 2018 Dec;49(12):3098-3106. doi: 10.1161/STROKEAHA.118.021010.
4
MicroRNA-126 in atherosclerosis.
Arterioscler Thromb Vasc Biol. 2014 Jul;34(7):e15-6. doi: 10.1161/ATVBAHA.114.303572. Epub 2014 May 15.
5
MiR-92a: at the heart of lipid-driven endothelial dysfunction.
Circ Res. 2014 Jan 31;114(3):399-401. doi: 10.1161/CIRCRESAHA.114.303125.
6
Exosomes: An emerging factor in atherosclerosis.
Biomed Pharmacother. 2019 Jul;115:108951. doi: 10.1016/j.biopha.2019.108951. Epub 2019 May 8.
7
Endothelial microRNAs and atherosclerosis.
Curr Atheroscler Rep. 2013 Dec;15(12):372. doi: 10.1007/s11883-013-0372-2.
8
MicroRNA-mediated mechanisms of the cellular stress response in atherosclerosis.
Nat Rev Cardiol. 2015 Jun;12(6):361-74. doi: 10.1038/nrcardio.2015.38. Epub 2015 Apr 7.
9
STAT3/miR-15a-5p/CX3CL1 Loop Regulates Proliferation and Migration of Vascular Endothelial Cells in Atherosclerosis.
Int J Med Sci. 2021 Jan 1;18(4):964-974. doi: 10.7150/ijms.49460. eCollection 2021.
10
Inhibition of microRNA-92a prevents endothelial dysfunction and atherosclerosis in mice.
Circ Res. 2014 Jan 31;114(3):434-43. doi: 10.1161/CIRCRESAHA.114.302213. Epub 2013 Nov 19.
引用本文的文献
1
A New Insight on Atherosclerosis Mechanism and Lipid-Lowering Drugs.
Rev Cardiovasc Med. 2025 Mar 5;26(3):25321. doi: 10.31083/RCM25321. eCollection 2025 Mar.
本文引用的文献
1
microRNA-483 ameliorates hypercholesterolemia by inhibiting PCSK9 production.
JCI Insight. 2020 Dec 3;5(23):143812. doi: 10.1172/jci.insight.143812.
2
Position-specific oxidation of miR-1 encodes cardiac hypertrophy.
Nature. 2020 Aug;584(7820):279-285. doi: 10.1038/s41586-020-2586-0. Epub 2020 Aug 5.
3
miR-483 Targeting of CTGF Suppresses Endothelial-to-Mesenchymal Transition: Therapeutic Implications in Kawasaki Disease.
Circ Res. 2017 Jan 20;120(2):354-365. doi: 10.1161/CIRCRESAHA.116.310233. Epub 2016 Dec 6.
4
Oxidative Modification of miR-184 Enables It to Target Bcl-xL and Bcl-w.
Mol Cell. 2015 Jul 2;59(1):50-61. doi: 10.1016/j.molcel.2015.05.003. Epub 2015 May 28.
5
RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease.
J Neurosci. 1999 Mar 15;19(6):1959-64. doi: 10.1523/JNEUROSCI.19-06-01959.1999.
Zotero 插件